Zai Lab (Shanghai)
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (18)
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Started: 11/30/2025
A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease
Started: 12/5/2025
A Study of Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer
Started: 8/20/2018
A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib
Started: 11/25/2020
A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST)
Started: 4/23/2020
A Study of Niraparib in Patients With Relapsed Ovarian Cancer
Started: 8/4/2020
A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC
Started: 5/17/2017
A Study of ZL-1310 in Participants With Selected Solid Tumors
Started: 5/12/2025
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
Started: 1/23/2024
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
Started: 3/1/2026
A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
Started: 12/1/2025
MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients
Started: 4/20/2020
A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma
Started: 10/29/2020
To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid Malignancies
Started: 6/16/2023
A Trial of ZL-1201 in Subjects With Advanced Cancer
Started: 5/11/2020
A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment
Started: 2/3/2020
A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBC
Started: 8/25/2020
The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer
Started: 12/19/2017